Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:42 PM
Ignite Modification Date:
2025-12-24 @ 7:42 PM
NCT ID:
NCT07271303
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years and ≤75 years, regardless of sex;
Patients scheduled to undergo painless gastrointestinal endoscopy examination or endoscopic surgery, which must include upper gastrointestinal endoscopy;
Voluntary participation based on the free will of the subject or their legal guardian, with signed informed consent form.
Exclusion Criteria:
* Here is the English translation for your Inclusion and Exclusion Criteria:
Inclusion Criteria
Age ≥18 years and ≤75 years, regardless of sex; Patients scheduled to undergo painless gastrointestinal endoscopy examination or endoscopic surgery, which must include upper gastrointestinal endoscopy; Voluntary participation based on the free will of the subject or their legal guardian, with signed informed consent form.
Exclusion Criteria
Patients with a history of upper gastrointestinal surgery or colorectal surgery; American Society of Anesthesiologists (ASA) classification ≥ Grade III; Patients with severe cardiac conditions, including severe arrhythmia, structural heart disease, or other serious cardiac disorders; Significant hepatic or renal dysfunction affecting drug metabolism, defined as ALT \> 2.5 × ULN, AST \> 2.5 × ULN, or Scr \> 1.5 × ULN; Organic pyloric stenosis, paralytic ileus, or other severe organic gastrointestinal diseases that are unsuitable for painless gastrointestinal endoscopy; Patients with suspected gastrointestinal ulcer bleeding or perforation; Patients with glaucoma or prostatic hypertrophy; Pregnant or lactating women; Known hypersensitivity to any component of the study drug; Use of medications affecting gastrointestinal motility within 7 days prior to study enrollment; Other conditions unsuitable for painless endoscopy procedures; Participation in another drug or medical device clinical trial within 30 days prior to study enrollment; Patients deemed unsuitable for participation in this clinical study by the investigator.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT07271303
Study Brief:
Protocol Section:
NCT07271303